Total Lymphocyte and CD4+T-cell Count Changes in Participants Receiving Islatravir (0.25mg, 0.75mg, and 2.25mg Once Daily) and Doravirine ±lamivudine: Post Hoc Analysis from a Phase 2b Dose-Ranging Study (P011)
HIV MEDICINE（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined